MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
1.160
-0.360
-23.68%
After Hours: 1.100 -0.06 -5.17% 19:59 03/28 EDT
OPEN
1.300
PREV CLOSE
1.520
HIGH
1.360
LOW
1.130
VOLUME
3.41M
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.2400
MARKET CAP
6.84M
P/E (TTM)
-0.4794
1D
5D
1M
3M
1Y
5Y
1D
Plus Therapeutics’ Optimistic Earnings Call Highlights
TipRanks · 1d ago
Plus Therapeutics Price Target Cut to $5.50/Share From $8.00 by HC Wainwright & Co.
Dow Jones · 1d ago
Plus Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 1d ago
Plus Therapeutics Is Maintained at Buy by D. Boral Capital
Dow Jones · 1d ago
Plus Therapeutics Price Target Maintained With a $9.00/Share by D. Boral Capital
Dow Jones · 1d ago
HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $5.5
Benzinga · 1d ago
D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $9 Price Target
Benzinga · 1d ago
Promising Outlook for Plus Therapeutics: Strategic Financial Moves and Innovative Assay Launch Justify Buy Rating
TipRanks · 1d ago
More
About PSTV
More
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium (186Re) obisbemeda, is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC). The Company’s Rhenium (186Re) obisbemeda, a novel injectable radiotherapy designed to deliver targeted, high dose radiation directly into GBM tumors. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers.
Recently
Symbol
Price
%Change

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.